Rallybio Corporaton (RLYB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 299 | 0 | 0 | 0 | 0 |
| Gross Profit | 299 | N/A | N/A | N/A | N/A |
| Operating Expenses | 17,334 | 19,787 | 21,112 | 19,363 | 20,083 |
| Operating Income | -17,035 | -19,787 | -21,112 | -19,363 | -20,083 |
| Other Income | 1,286 | 1,443 | 1,483 | 1,637 | 1,670 |
| Pre-tax Income | -15,749 | -18,344 | -19,629 | -17,726 | -18,413 |
| Net Income Continuous | -16,236 | -19,029 | -20,242 | -18,374 | -18,630 |
| Net Income | $-16,236 | $-19,029 | $-20,242 | $-18,374 | $-18,630 |
| EPS Basic Total Ops | -0.37 | -0.47 | -0.50 | -0.45 | -0.46 |
| EPS Basic Continuous Ops | -0.37 | -0.47 | -0.50 | -0.45 | -0.46 |
| EPS Diluted Total Ops | -0.37 | -0.47 | -0.50 | -0.45 | -0.46 |
| EPS Diluted Continuous Ops | -0.37 | -0.47 | -0.50 | -0.45 | -0.46 |
| EPS Diluted Before Non-Recurring Items | -0.37 | -0.47 | -0.50 | N/A | N/A |
| EBITDA(a) | $-17,417 | $-20,291 | $-21,733 | $-20,029 | $-20,879 |